|
|
|
|
| LEADER |
00000cam a2200000Ma 4500 |
| 001 |
ocn927456881 |
| 003 |
OCoLC |
| 005 |
20240809213013.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
090713s2015 nju ob 001 u eng d |
| 040 |
|
|
|a RECBK
|b eng
|e pn
|c RECBK
|d OCLCO
|d EBLCP
|d OCLCF
|d OCLCQ
|d OCLCO
|d COO
|d OCLCQ
|d LOA
|d STF
|d CCO
|d PIFAG
|d FVL
|d MERUC
|d OCLCQ
|d ZCU
|d U3W
|d DEBBG
|d WRM
|d COCUF
|d ICG
|d OCLCQ
|d TKN
|d DKC
|d OCLCQ
|d UKAHL
|d OCLCQ
|d TUHNV
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|d OCLCL
|d UEJ
|d OCLCQ
|
| 019 |
|
|
|a 929527951
|
| 020 |
|
|
|a 9781119041436
|q (electronic bk.)
|
| 020 |
|
|
|a 1119041430
|q (electronic bk.)
|
| 020 |
|
|
|a 9781119041429
|
| 020 |
|
|
|a 1119041422
|
| 028 |
0 |
1 |
|a EB00625231
|b Recorded Books
|
| 035 |
|
|
|a (OCoLC)927456881
|z (OCoLC)929527951
|
| 050 |
|
4 |
|a RM666.P797
|b H363 2015eb
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Kumar Thakur, Vijay.
|
| 245 |
1 |
0 |
|a Handbook of polymers for pharmaceutical technologies :
|b volume 3, biodegradable polymers /
|c Vijay Kumar Thakur and Manju Kumari Thakur.
|
| 260 |
|
|
|a Hoboken, NJ :
|b Wiley,
|c 2015.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a IN PROCESS RECORD.
|
| 500 |
|
|
|a Title from resource description page (Recorded Books, viewed November 02, 2015).
|
| 505 |
0 |
|
|a Half Title page; Title page; Copyright page; Dedication; Preface; Chapter 1: Bioactive Polysaccharides of Vegetable and Microbial Origins: An Overview; 1.1 Introduction; 1.2 Anticarcinogenic Polysaccharides; 1.3 Anti-inflammatory/Immunostimulating Polysaccharides; 1.4 Antiviral Polysaccharides; 1.5 Antioxidant Polysaccharides; 1.6 Other Biotechnological Applications; 1.7 Conclusions and Future Perspectives; Acknowledgments; References; Chapter 2: Chitosan: An Emanating Polymeric Carrier for Drug Delivery; 2.1 Introduction; 2.2 Preparation of Chitosan.
|
| 505 |
8 |
|
|a 2.3 Physicochemical Properties of Chitosan2.4 Biological Activities of Chitosan; 2.5 Pharmaceutical Applications of Chitosan; 2.6 Functionalization of Chitosan; 2.7 Conclusion and Future Perspectives; References; Chapter 3: Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications; 3.1 Introduction; 3.2 The Fungal Cell; 3.3 Polysaccharides Produced by Fungi; 3.4 Production and Extraction of Polysaccharides from Fungi; 3.5 Fungal Polysaccharides in Biomedical and Pharmaceutical Applications.
|
| 505 |
8 |
|
|a 3.6 Commercial Exploitation of Fungal Polysaccharides in Biomedical and Pharmaceutical Applications3.7 Conclusion and Future Perspective; References; Chapter 4: Environmentally Responsive Chitosan-based Nanocarriers (CBNs); 4.1 Introduction; 4.2 Graft Copolymerized CBNs; 4.3 pH-Sensitive CBNs; 4.4 Thermosensitive CBNs; 4.5 pH-Sensitive and Thermosensitive CBNs; 4.6 pH- and Ionic-Sensitive CBNs; 4.7 Photosensitive CBNs; 4.8 Electrical-Sensitive CBNs; 4.9 Magneto-Responsive CBNs; 4.10 Chemo-Sensitive CBNs; 4.11 Biodegradation of Chitosan and Its Derivatives; 4.12 Toxicity of CBNs.
|
| 505 |
8 |
|
|a 4.13 Conclusions and Future PerspectivesReferences; Chapter 5: Biomass Derived and Biomass Inspired Polymers in Pharmaceutical Applications; 5.1 Introduction; 5.2 Biodegradable Polymers in Biomedical Applications -- Relevant Aspects; 5.3 Biodegradable Natural Polymers in Pharmaceutical Applications; 5.4 Micro- and Nanocrystalline Natural Polymers and Fibrils -- General Regulative Considerations; 5.5 Concluding Remarks and Outlook; References; Chapter 6: Modification of Cyclodextrin for Improvement of Complexation and Formulation Properties; Abbrevations:; 6.1 Introduction.
|
| 505 |
8 |
|
|a 6.2 Cyclodextrin and Its Degradation6.3 Complexation by CDs and Release; 6.4 Modifications and Scope with Respect to Pharmaceutical Application; 6.5 Concluding Remarks; Acknowledgements; References; Chapter 7: Cellulose-, Ethylene Oxide- and Acrylic-Based Polymers in Assembled Module Technology (Dome Matrix®); 7.1 Dome Matrix® Technology; 7.2 Polymers for Controlled Drug Release; 7.3 Cellulose Derivatives; 7.4 Acrylic Acid Polymers; 7.5 Polymethacrylates; 7.6 Polyethylene Oxide; 7.7 Conclusions; Acknowledgments; References; Chapter 8: Structured Biodegradable Polymers for Drug Delivery.
|
| 504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
| 650 |
|
0 |
|a Technology.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Chemical & Biochemical.
|2 bisacsh
|
| 650 |
|
7 |
|a Pharmaceutical technology
|2 fast
|
| 650 |
|
7 |
|a Technology
|2 fast
|
| 700 |
1 |
|
|a Kumari Thakur, Manju.
|
| 758 |
|
|
|i has work:
|a Biodegradable polymers volume 3 Handbook of polymers for pharmaceutical technologies (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGykp8km9YcjM87JkHXwyb
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Thakur, Vijay Kumar.
|t Handbook of Polymers for Pharmaceutical Technologies, Biodegradable Polymers.
|d : Wiley, ©2015
|z 9781119041429
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=4040721
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|